Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
10/11/2022 21:49
Nov 10 (Reuters) - Bellicum Pharmaceuticals Inc
BLCM.O :
* BELLICUM REPORTS THIRD QUARTER 2022 FINANCIAL RESULTS AND
PROVIDES OPERATIONAL UPDATE
* BELLICUM PHARMACEUTICALS INC Q3 REVENUE $1.0 MILLION
* BELLICUM PHARMACEUTICALS INC- QTRLY NET LOSS PER COMMON
SHARE
ATTRIBUTABLE TO COMMON SHAREHOLDERS, DILUTED$0.23
Source text for Eikon: ID:nGNX2k7PNd
Further company coverage: BLCM.O
((Reuters.Briefs@thomsonreuters.com;;))
Recent news on Bellicum Pharmaceuticals
See all newsBrief: Bellicum Pharmaceuticals- In Connection With Dissolution And Plan Of Dissolution, On February 23, Richard A. Fair Resigned As President And Co's CEO
Brief: Bellicum Pharmaceuticals Says Board Approved Liquidation And Dissolution Of Co In Connection With Approval Of Asset Purchase Agreement
Brief: Bellicum Pharmaceuticals Initiated A 12 Stock Split On Dec 8, 2022
Brief: Bellicum Reports Third Quarter 2022 Financial Results And Provides Operational Update
Bellicum Pharmaceuticals Inc expected to post a loss of 64 cents a share - Earnings Preview